• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Sunday, April 11, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Science

Wide variability in generic heart failure drugs can make them unaffordable to uninsured

Bioengineer by Bioengineer
November 15, 2016
in Science
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Photo by Ellen Hutti, Saint Louis University.

ST. LOUIS – New research from Saint Louis University finds that the prices for commonly used generic heart failure drugs varies widely.

A team of researchers led by Paul J. Hauptman, M.D., a SLUCare cardiologist specializing in heart failure and professor of internal medicine at Saint Louis University School of Medicine, found that the cost of the drugs charged at retail pharmacies may vary so widely that uninsured patients may not be able to afford them. The research was highlighted at the American Heart Association's Scientific Sessions 2016 on Nov. 15.

A research letter also was published in JAMA Internal Medicine.

"The idea for the study originated with one of our patients, a 25-year-old man with heart failure, who called the office and said he could not afford to fill a prescription for digoxin," Hauptman said. "When I found out that a month's supply was going to cost him $100, I couldn't believe it. Like me, I think a lot of doctors assume that if you're writing a prescription for a generic drug that it will be affordable — and that's not necessarily the case."

An estimated 7.3 million Americans with cardiovascular disease are underinsured or uninsured.

Hauptman and his team surveyed 175 pharmacies in the bi-state St. Louis region to determine what they charged uninsured customers for three generic guideline-directed medicines (Digoxin, Lisinopril and Carvedilol) used to treat heart failure. The pharmacies were queried during a three-week period in May and data were provided from 153 chain stores and 22 independently-owned pharmacies in 55 different zip codes.

The 30-day cash purchase price for the three drugs ranged from $20.19 to $256.77 for the low doses of the drugs, with a median price of $67.98; and $12 to $397.58 for the high doses of the drugs, with a median price of $70.68. Similar data were obtained for 90-day supplies.

Digoxin, the oldest medication, was the most expensive of the three.

The study did not find a link between price, area and type of pharmacy. Zip code and median income clusters in the region also did not demonstrate differences so that pharmacy location did not predict pricing.

The researchers also found that prices varied even at stores owned by a single major pharmacy chain. Mail order pharmacies were not included as they are not an available option for most uninsured and underinsured patients.

Patients with heart failure commonly take five or six medications, Hauptman said. Patients in low income areas, who may be at highest risk of complications from heart failure may not have convenient access to multiple pharmacies to price shop for the cheapest medication, leaving them vulnerable to lapses in adherence.

Since a greater understanding of pricing practices at the retail pharmacy level is required, the researchers recommend that the study be replicated in other geographic areas and with different generic drugs to treat other medical conditions. At the same time, Hauptman indicated that there are potential health policy implications based on the current data and that from the patient perspective, the variability seen at the pharmacy can be very difficult to manage.

###

Co-authors are Zackary D. Goff, B.S., a fourth-year SLU medical student; Andrija Vidic, D.O.; John T. Chibnall, Ph.D., Saint Louis University School of Medicine; and Barry E. Bleske, Pharm.D., professor of Pharmacy Practice & Administrative Sciences, College of Pharmacy, University of New Mexico.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: infectious disease, liver disease, cancer, heart/lung disease, and aging and brain disorders.

Media Contact

Maggie Rotermund
[email protected]
314-977-8018
@SLU_Official

http://www.slu.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Five or more hours of smartphone usage per day may increase obesity

July 25, 2019
IMAGE

NASA’s terra satellite finds tropical storm 07W’s strength on the side

July 25, 2019

NASA finds one burst of energy in weakening Depression Dalila

July 25, 2019

Researcher’s innovative flood mapping helps water and emergency management officials

July 25, 2019

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    851 shares
    Share 340 Tweet 213
  • Jonathan Wall receives $1.79 million to develop new amyloidosis treatment

    59 shares
    Share 24 Tweet 15
  • UofL, Medtronic to develop epidural stimulation algorithms for spinal cord injury

    56 shares
    Share 22 Tweet 14
  • A sturdier spike protein explains the faster spread of coronavirus variants

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Cell BiologyGeneticsMedicine/HealthClimate ChangeInfectious/Emerging DiseasesTechnology/Engineering/Computer SciencePublic HealthMaterialscancerEcology/EnvironmentChemistry/Physics/Materials SciencesBiology

Recent Posts

  • MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
  • Men with low health literacy less likely to choose active surveillance for prostate cancer after tumor profiling
  • Level of chromosomal abnormality in lung cancer may predict immunotherapy response
  • Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In